1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...
Image: PD 1. Romosozumab, an anti-sclerostin antibody, significantly increased bone mineral density in postmenopausal women compared to placebo. 2. When ...
Image: PD/Tau Protein Alzheimer Disease In this section, we will highlight the key high-impact studies, updates, and analyses published in ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
